Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ju-Min Huang

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Pharmacological Research|May 8, 2021
Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8<sup>+</sup> T cellsZe-Bo Jiang, Cong Xu, Wenjun Wang, et al.
Cancer Letters|May 30, 2021
Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancerZe-Bo Jiang, Wen-Jun Wang, Cong Xu, et al.
International Journal of Cancer|February 21, 2019
Identification of a new inhibitor of KRAS-PDEδ interaction targeting KRAS mutant nonsmall cell lung cancerElaine Lai-Han Leung, Lian Xiang Luo, Ying Li, et al.
Pharmacological Research|July 15, 2023
CERS4 predicts positive anti-PD-1 response and promotes immunomodulation through Rhob-mediated suppression of CD8<sup>+</sup>Tim3<sup>+</sup> exhausted T cells in non-small cell lung cancerJian Wang, Run-Ze Li, Wen-Jun Wang, et al.
Pharmacological Research|March 22, 2023
β-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancerCong Xu, Ze-Bo Jiang, Le Shao, et al.
Pharmacological Research|August 22, 2021
Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signalingJia-Xin Li, Run-Ze Li, Ao Sun, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Pharmacological Research|May 8, 2021
Plumbagin suppresses non-small cell lung cancer progression through downregulating ARF1 and by elevating CD8<sup>+</sup> T cellsZe-Bo Jiang, Cong Xu, Wenjun Wang, et al.
Cancer Letters|May 30, 2021
Luteolin and its derivative apigenin suppress the inducible PD-L1 expression to improve anti-tumor immunity in KRAS-mutant lung cancerZe-Bo Jiang, Wen-Jun Wang, Cong Xu, et al.
International Journal of Cancer|February 21, 2019
Identification of a new inhibitor of KRAS-PDEδ interaction targeting KRAS mutant nonsmall cell lung cancerElaine Lai-Han Leung, Lian Xiang Luo, Ying Li, et al.
Pharmacological Research|July 15, 2023
CERS4 predicts positive anti-PD-1 response and promotes immunomodulation through Rhob-mediated suppression of CD8<sup>+</sup>Tim3<sup>+</sup> exhausted T cells in non-small cell lung cancerJian Wang, Run-Ze Li, Wen-Jun Wang, et al.
Pharmacological Research|March 22, 2023
β-Elemene enhances erlotinib sensitivity through induction of ferroptosis by upregulating lncRNA H19 in EGFR-mutant non-small cell lung cancerCong Xu, Ze-Bo Jiang, Le Shao, et al.
Pharmacological Research|August 22, 2021
Metabolomics and integrated network pharmacology analysis reveal Tricin as the active anti-cancer component of Weijing decoction by suppression of PRKCA and sphingolipid signalingJia-Xin Li, Run-Ze Li, Ao Sun, et al.
Pageof 2